FOURTH OMNIBUS AMENDMENTFourth Omnibus • May 14th, 2012 • Galena Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledMay 14th, 2012 Company IndustryThis FOURTH OMNIBUS AMENDMENT (this “Fourth Amendment”) is made and entered into as of April 3, 2012, by and among Tang Capital Partners, LP, RTW Investments, LLC, Galena Biopharma, Inc. (formerly RXi Pharmaceuticals Corporation) and RXi Pharmaceuticals Corporation (formerly RNCS, Inc.).
SIXTH OMNIBUS AMENDMENTGalena Biopharma, Inc. • May 14th, 2012 • Pharmaceutical preparations
Company FiledMay 14th, 2012 IndustryThis SIXTH OMNIBUS AMENDMENT (this “Sixth Amendment”) is made and entered into as of April 18, 2012, by and among Tang Capital Partners, LP, RTW Investments, LLC, Galena Biopharma, Inc. (formerly RXi Pharmaceuticals Corporation) and RXi Pharmaceuticals Corporation (formerly RNCS, Inc.).
SEVENTH AMENDMENT AGREEMENTSeventh Amendment Agreement • May 14th, 2012 • Galena Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledMay 14th, 2012 Company IndustryThis SEVENTH AMENDMENT AGREEMENT (this “Seventh Amendment”) is made and entered into as of April 25, 2012, by and among Tang Capital Partners, LP, RTW Investments, LLC, Galena Biopharma, Inc. (formerly RXi Pharmaceuticals Corporation, “Galena”) and RXi Pharmaceuticals Corporation (formerly RNCS, Inc., “RXi”).
FIFTH OMNIBUS AMENDMENTGalena Biopharma, Inc. • May 14th, 2012 • Pharmaceutical preparations
Company FiledMay 14th, 2012 IndustryThis FIFTH OMNIBUS AMENDMENT (this “Fifth Amendment”) is made and entered into as of April 11, 2012, by and among Tang Capital Partners, LP, RTW Investments, LLC, Galena Biopharma, Inc. (formerly RXi Pharmaceuticals Corporation) and RXi Pharmaceuticals Corporation (formerly RNCS, Inc.).
THIRD OMNIBUS AMENDMENTThird Amendment • May 14th, 2012 • Galena Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledMay 14th, 2012 Company IndustryThis THIRD OMNIBUS AMENDMENT (this “Third Amendment”) is made and entered into as of March 30, 2012, by and among Tang Capital Partners, LP, RTW Investments, LLC, Galena Biopharma, Inc. (formerly RXi Pharmaceuticals Corporation) and RXi Pharmaceuticals Corporation (formerly RNCS, Inc.).